On Sep 13, 2021 TreeFrog Therapeutics closed a Series B round and raised €64,000,000 from Bpifrance, Bristol Myers Squibb, Leonard Green & Partners, XAnge, featuring lead investors Bpifrance.

About the company: TreeFrog Therapeutics is located at France, Europe.
“TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.”

Company website: http://www.treefrog.fr